Snowden Capital Advisors LLC Astrazeneca PLC Transaction History
Snowden Capital Advisors LLC
- $3.02 Billion
- Q1 2025
A detailed history of Snowden Capital Advisors LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Snowden Capital Advisors LLC holds 42,686 shares of AZN stock, worth $3.11 Million. This represents 0.1% of its overall portfolio holdings.
Number of Shares
42,686
Previous 43,428
1.71%
Holding current value
$3.11 Million
Previous $2.85 Million
10.26%
% of portfolio
0.1%
Previous 0.09%
Shares
39 transactions
Others Institutions Holding AZN
# of Institutions
1,428Shares Held
504MCall Options Held
10MPut Options Held
3.14M-
Price T Rowe Associates Inc Baltimore, MD57.1MShares$4.16 Billion0.52% of portfolio
-
Primecap Management CO Pasadena, CA40.7MShares$2.96 Billion2.53% of portfolio
-
Wellington Management Group LLP Boston, MA35.6MShares$2.59 Billion0.52% of portfolio
-
Bank Of America Corp Charlotte, NC31.8MShares$2.32 Billion0.19% of portfolio
-
Capital International Investors Los Angeles, CA31.3MShares$2.28 Billion0.47% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $226B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...